Washington University in St. Louis School of Medicine-ko ikertzaileekin lankidetzan egindako argitalpenak (69)

2024

  1. C-reactive Protein and Risk of Right Ventricular Dysfunction and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

    Archivos de Bronconeumologia, Vol. 60, Núm. 6, pp. 344-349

  2. High-Sensitivity vs Conventional Troponin Cutoffs for Risk Stratification in Patients with Acute Pulmonary Embolism

    JAMA Cardiology, Vol. 9, Núm. 1, pp. 64-70

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. National Early Warning Score-2 for Identification of Patients with Intermediate-High-Risk Pulmonary Embolism

    Seminars in Thrombosis and Hemostasis, Vol. 49, Núm. 7, pp. 716-724

  3. Revised Paradigm for Acute Pulmonary Embolism Prognostication and Treatment

    American journal of respiratory and critical care medicine, Vol. 208, Núm. 5, pp. 524-527

2022

  1. Randomised controlled trial of a prognostic assessment and management pathway to reduce the length of hospital stay in normotensive patients with acute pulmonary embolism

    The European respiratory journal, Vol. 59, Núm. 2

2021

  1. Effect of a Pulmonary Embolism Diagnostic Strategy on Clinical Outcomes in Patients Hospitalized for COPD Exacerbation: A Randomized Clinical Trial

    JAMA - Journal of the American Medical Association, Vol. 326, Núm. 13, pp. 1277-1285

2020

  1. Systolic blood pressure and mortality in acute symptomatic pulmonary embolism

    International Journal of Cardiology, Vol. 302, pp. 157-163

2019

  1. Accuracy and Interobserver Reliability of the Simplified Pulmonary Embolism Severity Index Versus the Hestia Criteria for Patients With Pulmonary Embolism

    Academic Emergency Medicine, Vol. 26, Núm. 4, pp. 394-401

  2. Comparison of All-Cause Mortality Following VTE Treatment Between Propensity Score-Adjusted Observational Studies and Matched Randomized Controlled Trials: Meta-Epidemiologic Study

    Chest, Vol. 155, Núm. 4, pp. 689-698

  3. Hospital volume and outcomes for acute pulmonary embolism: Multinational population based cohort study

    The BMJ, Vol. 366

  4. Meta-Analysis of Prevalence and Short-Term Prognosis of Hemodynamically Unstable Patients With Symptomatic Acute Pulmonary Embolism

    American Journal of Cardiology, Vol. 123, Núm. 4, pp. 684-689

  5. The rationale, design, and methods of a randomized, controlled trial to evaluate the efficacy and safety of an active strategy for the diagnosis and treatment of acute pulmonary embolism during exacerbations of chronic obstructive pulmonary disease

    Clinical Cardiology, Vol. 42, Núm. 3, pp. 346-351

2018

  1. Assessment of coexisting deep vein thrombosis for risk stratification of acute pulmonary embolism

    Thrombosis Research, Vol. 164, pp. 40-44

  2. Diclofenac for reversal of right ventricular dysfunction in acute normotensive pulmonary embolism: A pilot study

    Thrombosis Research, Vol. 162, pp. 1-6

  3. Efficacy and safety outcomes of recanalisation procedures in patients with acute symptomatic pulmonary embolism: systematic review and network meta-analysis

    Thorax, Vol. 73, Núm. 5, pp. 464-471

  4. Epidemiology, patterns of care and mortality for patients with hemodynamically unstable acute symptomatic pulmonary embolism

    International Journal of Cardiology, Vol. 269, pp. 327-333

  5. Management appropriateness and outcomes of patients with acute pulmonary embolism

    European Respiratory Journal, Vol. 51, Núm. 5

  6. Outpatient therapy for acute symptomatic pulmonary embolism diagnosed in the emergency department: Time to improve the evidence base

    Thrombosis Research

  7. Performance of Early Prognostic Assessment Independently Predicts the Outcomes in Patients with Acute Pulmonary Embolism

    Thrombosis and Haemostasis